On Aug. ten, the FDA dominated to reject copyright for assisted psychotherapy for PTSD, citing inadequate evidence and the need for more exploration. The ruling is according to a letter APA sent the FDA earlier this year that mentioned that an assessment with the literature on copyright-assisted psychotherapy by a multidisciplinary panel of gurus d